1
1

index-about
社團法人台灣肝病醫療策進會Advancing Clinical Treatment – Liver Disease (ACT-LD) 為一國際權威肝病防治組織,成立目標即在於藉由提升民眾對於肝病的認知,加強醫學界對肝病相關重大進展的了解,來改善病人的照顧品質與治療結果。2004年台灣肝病醫療策進會於美國成立運作,2005年年初擴展到B型肝炎盛行之亞太地區,分別在亞太十四個國家成立分會。一向對台灣肝病防治不遺餘力、成績有目共睹的台灣,也於2005年11月29日正式宣布台灣分會成立。

C肝新藥給付 盼再增3萬名額

| 最新消息 | No Comments

〔記者林惠琴/台北報導〕衛福部健保署今年原本編列六十五.三六…

C肝藥專款預計8月用罄 健保署拚尋財源

| 最新消息 | No Comments

C肝藥專款預計8月用罄 健保署拚尋財源 健保今年起全面給付現…

健保擬再砸40億滅C肝!6月起降低門檻 符合「這條件」就給藥

| 最新消息 | No Comments

▲健保署長李伯璋。(圖/記者嚴云岑攝) 記者嚴云岑/台北報導…

On 28 May, 194 Member States made a historic commitment to eliminate viral hepatitis by 2030. At the 69th World Health Assembly, governments unanimously voted to adopt the first ever Global Viral Hepatitis Strategy, signalling the greatest global commitment in viral hepatitis to date. The Strategy sets a goal of eliminating hepatitis B and C by 2030 and includes a set of prevention and treatment targets which, if reached, will reduce annual deaths by 65% and increase treatment to 80%, saving 7.1 million lives globally by 2030. Share this video and support NOhep.org on World Hepatitis Day (28 July 2016) to ensure governments countries honour their commitment to making the elimination of viral hepatitis our next greatest achievement.